A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival

MOCROFT A. ; MADGE S. ; A. M. JOHNSON ; A. LAZZARIN ; CLUMECK N. ; GOEBEL F. D. ; VIARD J. P. ; GATELL J. ; BLAXHULT A. ; J. D. LUNDGREN | 1999
Périodique

ENGLISH : BACKGROUND: Concerns have been raised that intravenous drug users may be less likely to start highly active antiretroviral therapy (HAART) and that adherence to therapy may be poor among this group of patients. Given the decreased mo[...]

Plus d'info

Ajouter à la sélection